Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
15.62
-0.30 (-1.88%)
At close: Apr 28, 2026, 4:00 PM EDT
15.63
+0.01 (0.06%)
After-hours: Apr 28, 2026, 5:53 PM EDT
Corvus Pharmaceuticals Employees
Corvus Pharmaceuticals had 37 employees as of December 31, 2025. The number of employees increased by 6 or 19.35% compared to the previous year.
Employees
37
Change (1Y)
6
Growth (1Y)
19.35%
Revenue / Employee
n/a
Profits / Employee
-$413,054
Market Cap
1.31B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Novavax | 749 |
| AbCellera Biologics | 562 |
| MapLight Therapeutics | 133 |
| Olema Pharmaceuticals | 131 |
| DBV Technologies | 117 |
| ArriVent BioPharma | 77 |
| GH Research | 73 |
CRVS News
- 5 days ago - Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D. - GlobeNewsWire
- 7 days ago - Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting - GlobeNewsWire
- 6 weeks ago - Corvus Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - GlobeNewsWire
- 2 months ago - Corvus Pharmaceuticals Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M - GlobeNewsWire